| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 150, 1647-1659, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
H Herbst, T Wege, S Milani, G Pellegrini, HD Orzechowski, WO Bechstein, P Neuhaus, AM Gressner and D Schuppan
Institute of Pathology, University Hospital Eppendorf, Hamburg, Germany.
The remodeling of extracellular matrix during chronic liver disease may partially be attributed to altered activity of matrix metalloproteinases and their tissue inhibitors (TIMPs). Expression of TIMP-1 and -2 was studied by in situ hybridization combined with immunohistochemistry in rat (acute and chronic carbon tetrachloride intoxication and secondary biliary fibrosis) and human livers and on isolated rat hepatic stellate cells. TIMP-1 and -2 transcripts appeared in rat livers within 1 to 3 hours after intoxication, pointing to a role in the protection against accidental activation of matrix metalloproteinases, and were present at high levels in all fibrotic rat and human livers predominantly in stellate cells. TIMP-2 RNA distribution largely matched with previously reported patterns of matrix metalloproteinase-2 (72-kd gelatinase) expression, suggesting generation of a TIMP-2/matrix metalloproteinase-2 complex (large inhibitor of metalloproteinases). Isolated stellate cells expressed TIMP-1 and -2 RNA. Addition of transforming growth factor-beta 1 enhanced TIMP-1 and matrix metalloproteinase-2 RNA levels in vitro, whereas TIMP-2-specific signals were reduced, likely to result in a stoichiometric excess of matrix-metalloproteinase-2 over TIMP-2. In the context of previous demonstrations of transforming growth factor-beta 1 and matrix metalloproteinase-2 in vivo, these patterns suggest an intrahepatic environment permitting only limited matrix degradation, ultimately resulting in redistribution of extracellular matrix with relative accumulation of collagen type 1.
This article has been cited by other articles:
![]() |
F. STICKEL and C. H. OSTERREICHER THE ROLE OF GENETIC POLYMORPHISMS IN ALCOHOLIC LIVER DISEASE Alcohol Alcohol., May 1, 2006; 41(3): 209 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Roderfeld, R. Weiskirchen, S. Wagner, M.-L. Berres, C. Henkel, J. Grotzinger, A. M. Gressner, S. Matern, and E. Roeb Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice FASEB J, March 1, 2006; 20(3): 444 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Novo, F Marra, E Zamara, L Valfre di Bonzo, A Caligiuri, S Cannito, C Antonaci, S Colombatto, M Pinzani, and M Parola Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells Gut, January 1, 2006; 55(1): 90 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
J G. Duplantier, L Dubuisson, N Senant, G Freyburger, I Laurendeau, J-M Herbert, A Desmouliere, and J Rosenbaum A role for thrombin in liver fibrosis Gut, November 1, 2004; 53(11): 1682 - 1687. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Galli, E Ceni, D W Crabb, T Mello, R Salzano, C Grappone, S Milani, E Surrenti, C Surrenti, and A Casini Antidiabetic thiazolidinediones inhibit invasiveness of pancreatic cancer cells via PPAR{gamma} independent mechanisms Gut, November 1, 2004; 53(11): 1688 - 1697. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Thirunavukkarasu, Y Yang, V M Subbotin, S A K Harvey, J Fung, and C R Gandhi Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats Gut, July 1, 2004; 53(7): 1010 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bodner-Adler, K. Bodner, O. Kimberger, K. Czerwenka, S. Leodolter, and K. Mayerhofer Expression of Matrix Metalloproteinases in Patients With Uterine Smooth Muscle Tumors: An Immunohistochemical Analysis of MMP-1 and MMP-2 Protein Expression in Leiomyoma, Uterine Smooth Muscle Tumor of Uncertain Malignant Potential, and Leiomyosarcoma Reproductive Sciences, April 1, 2004; 11(3): 182 - 186. [Abstract] [PDF] |
||||
![]() |
B. Bodner-Adler, K. Bodner, O. Kimberger, K. Czerwenka, S. Leodolter, and K. Mayerhofer MMP-1 and MMP-2 Expression in Uterine Leiomyosarcoma and Correlation With Different Clinicopathologic Parameters Reproductive Sciences, October 1, 2003; 10(7): 443 - 446. [Abstract] [PDF] |
||||
![]() |
U. Schlotzer-Schrehardt, J. Lommatzsch, M. Kuchle, A. G. P. Konstas, and G. O. H. Naumann Matrix Metalloproteinases and Their Inhibitors in Aqueous Humor of Patients with Pseudoexfoliation Syndrome/Glaucoma and Primary Open-Angle Glaucoma Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1117 - 1125. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Perez, A. Suarez, J. A. Gomez-Capilla, F. Sanchez-Medina, and A. Gil Dietary Nucleotide Supplementation Reduces Thioacetamide-Induced Liver Fibrosis in Rats J. Nutr., April 1, 2002; 132(4): 652 - 657. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Raetsch, J D Jia, G Boigk, M Bauer, E G Hahn, E-O Riecken, and D Schuppan Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis Gut, February 1, 2002; 50(2): 241 - 247. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sedlaczek, J.-D. Jia, M. Bauer, H. Herbst, M. Ruehl, E. G. Hahn, and D. Schuppan Proliferating Bile Duct Epithelial Cells Are a Major Source of Connective Tissue Growth Factor in Rat Biliary Fibrosis Am. J. Pathol., April 1, 2001; 158(4): 1239 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. P. Arthur Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis Am J Physiol Gastrointest Liver Physiol, August 1, 2000; 279(2): G245 - G249. [Abstract] [Full Text] [PDF] |
||||
![]() |
R C BENYON and J P IREDALE Is liver fibrosis reversible? Gut, April 1, 2000; 46(4): 443 - 446. [Full Text] [PDF] |
||||
![]() |
U. Gunther, D. Schuppan, M. Bauer, H. Matthes, A. Stallmach, A. Schmitt-Graff, E.-O. Riecken, and H. Herbst Fibrogenesis and Fibrolysis in Collagenous Colitis : Patterns of Procollagen Types I and IV,Matrix-Metalloproteinase-1 and -13, and TIMP-1 Gene Expression Am. J. Pathol., August 1, 1999; 155(2): 493 - 503. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Daum, U Bauer, H-D Foss, D Schuppan, H Stein, E-O Riecken, and R Ullrich Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease Gut, January 1, 1999; 44(1): 17 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Kossakowska, D. R. Edwards, S. S. Lee, L. S. Urbanski, A. L. Stabbler, C.-L. Zhang, B. W. Phillips, Y. Zhang, and S. J. Urbanski Altered Balance Between Matrix Metalloproteinases and Their Inhibitors in Experimental Biliary Fibrosis Am. J. Pathol., December 1, 1998; 153(6): 1895 - 1902. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. GUNTHER, H. MATTHES, H. HERBST, A. STALLMACH, E. O. RIECKEN, and D. SCHUPPAN Phenotype of Cells Expressing Matrix Metalloproteinase-3 in Ulcerative Colitis Ann. N.Y. Acad. Sci., November 17, 1998; 859(1): 237 - 240. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |